Novel, acidic CCR2 receptor antagonists: From hit to lead

被引:15
|
作者
Zou, D.
Zhai, H. A.
Eckman, J.
Higgins, P.
Gillard, M.
Knerr, L.
Carre, S.
Pasau, P.
Collart, P.
Grassi, J.
Libertine, L.
Nicolas, J. -M.
Schwartz, C. E.
机构
[1] UCB Res Inc, Cambridge, MA 02139 USA
[2] UCB Pharma, B-1420 Braine lAlleud, Belgium
关键词
MCP-1; CCR2; chemokine receptor; antagonist; inflammation; hit to lead;
D O I
10.2174/157018007780077381
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High throughput screening identified a pyrrolidinone containing acidic functionality as a CCR2 antagonist of modest affinity. We describe initial SAR around this hit, including solution phase parallel synthesis for analog preparation, and we describe identification and characterization of an analog subsequently selected as a viable lead molecule for further optimization.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [31] The CCR2 receptor as a therapeutic target
    Feria, M
    Díaz-González, F
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (01) : 49 - 57
  • [32] Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2)
    Zacarias, Natalia V. Ortiz
    Roth, Sascha
    Broekhuis, Jeremy D.
    van der Es, Daan
    Moreau, Kevin
    Heitman, Laura H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [33] Inducing receptor degradation as a novel approach to target CC chemokine receptor 2 (CCR2)
    Zacarias, Natalia Ortiz
    Broekhuis, Jeremy
    van der Es, Daan
    Heitman, Laura H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 657 - 658
  • [34] From HTS hit to CD: Optimization of a novel series of CCR4 antagonists
    Mete, Antonio
    Andrews, Glen
    Baxter, Andrew
    Cheshire, David
    Ewart, Lorna
    Harper, Steve
    Hickling, Kevin
    Kindon, Nicholas
    McGinnity, Dermot
    Murray, Claire
    Stocks, Michael
    Tomkinson, Nicholas
    Wregget, Keith
    Young, Simon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [35] γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Mo, Ruowei
    Meyer, Dayton T.
    Voss, Matthew E.
    Yang, Michael G.
    Santella, Joseph B., III
    Duncia, John V.
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Zhao, Qihong
    Mandlekar, Sandhya
    Cvijic, Mary Ellen
    Barrish, Joel C.
    Decicco, Carl P.
    Carter, Percy H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2425 - 2430
  • [36] Sulfone-containing trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Mo, Ruowei
    Meyer, Dayton T.
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Zhao, Qihong
    Mandlekar, Sandhya
    Cvijic, Mary Ellen
    Tebben, Andrew J.
    Carter, Percy H.
    Barrish, Joel C.
    Decicco, Carl P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [37] Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Moa, Ruowei
    Yang, Michael G.
    Xiao, Zili
    Zhao, Qihong
    Mandlekar, Sandhya
    Cvijic, Mary Ellen
    Charo, Israel F.
    Barrish, Joel C.
    Decicco, Carl P.
    Carter, Percy H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (07) : 1843 - 1845
  • [38] Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A Antagonists
    Yamada, Toru
    Mihara, Kousuke
    Ueda, Taichi
    Yamauchi, Daisuke
    Shimizu, Masaya
    Ando, Azusa
    Mayumi, Kei
    Nakata, Zenzaburo
    Mikamiyama, Hidenori
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (13) : 11197 - 11208
  • [39] Rational design of CCR2 antagonists: a survey of computational studies
    Sobhia, Masilamani Elizabeth
    Singh, Rajesh
    Kare, Pavan
    Chavan, Swapnil
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (06) : 543 - 557
  • [40] CCR2 chemokine receptor and AIDS progression
    Smith, MW
    Carrington, M
    Winkler, C
    Lomb, D
    Dean, M
    Huttley, G
    OBrien, SJ
    NATURE MEDICINE, 1997, 3 (10) : 1052 - 1053